March 1, 2017
Curtis advises leading pharmaceutical company Fidia Farmaceutici on acquisition of Sooft Group
Curtis Italy has assisted leading Italian pharmaceutical company, Fidia Farmaceutici, in the negotiation and signing of an agreement for the acquisition of Sooft Group, a key player in the ophthalmic market.
With the acquisition of the Sooft Group know-how, Fidia Farmaceutici enhances its ability to innovate, cements its position within the Italian market and acquires a strategic presence in key international pharmaceutical and biomedical markets. Fidia’s turnover is projected to increase to Euro 300 million in 2017 as a result of the deal.
The transaction, which signed on February 24, 2017, was covered by the Italian business and legal media.
The team was led by Milan based partner Ian Tully and Rome based partner Alfonso de Marco, and included counsel Carmine Gravina and Marco Guilizzoni (for labor law issues), associates Francesco Fortuna and Rosanna Pallotta, and trainees Marta Falcone, Letizia Ceccarelli, Alessandro Bianchi and Valerio Cellentani.